Collecting duct is a site of sodium retention in PAN nephrosis: A rationale for amiloride therapy

Journal of the American Society of Nephrology

Volumn 12, Issue 3, 2001, Pages 598-601

  Deschenes G ^a   Wittner, M ^a   Di Stefano, A ^a   Jounier, S ^a   Doucet, A ^a  

^a CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; ALDOSTERONE ANTAGONIST; ALDOSTERONE RECEPTOR; AMILORIDE; CANRENOATE POTASSIUM; DIURETIC AGENT; FUROSEMIDE; SODIUM; SODIUM CHANNEL BLOCKING AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASCITES; CONTROLLED STUDY; DRUG EFFECT; DRUG POTENCY; KIDNEY COLLECTING TUBULE; KIDNEY PERFUSION; MALE; NEPHROSIS; NONHUMAN; PRIORITY JOURNAL; RAT; SODIUM ABSORPTION; SODIUM RETENTION; SODIUM TRANSPORT; SODIUM URINE LEVEL;

EID: 0035126825     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Role for intrarenal mechanisms in the impaired salt excretion of experimental nephrotic syndrome
2. Collecting duct Na,K-ATPase activity correlates with urinary sodium excretion in rat nephrotic syndromes
3. Differential effects of ADH on sodium, chloride, potassium, calcium and magnesium transport in cortical and medullary thick ascending limbs of mouse nephron
4. + transport in rat CCD
5. Na,K-ATPase activity and hormones in single nephron segments from nephrotic rats
6. Mechanism of enhanced Na,K-ATPase activity in cortical collecting duct from rats with nephrotic syndrome
7. Effect of "high ceiling" diuretics on active salt transport in the cortical thick ascending limb of Henle's loop of rabbit kidney
8. Tubular resistance to furosemide contributes to the attenuated diuretic response in nephrotic rats
9. Binding inhibitors restore furosemide potency in tubule fluid containing albumin
10. Urinary protein binding does not affect response to furosemide in patients with nephrotic syndrome
11. Mechanisms of edema in experimental nephrosis
12. The effect of atrial natriuretic peptide infusion on renal haemodynamics and plasma lipoproteins in puromycin aminonucleoside nephrosis in rats
13. Pathophysiology of experimental nephrotic syndrome induced by puromycin aminonucleoside in rats. III. Effect of captopril, an angiotensin converting enzyme inhibitor
14. Controlled clinical study on 2 antialdosterone diuretics in the nephrotic syndrome
15. Hyporeninemic hypoaldosteronism in patients with nephrotic syndrome
16. Role of aldosterone in the sodium retention of patients with nephrotic syndrome